5:29 PM
 | 
Oct 18, 2013
 |  BC Extra  |  Company News

GSK, Genmab seek to extend U.S. label for Arzerra

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and partner Genmab A/S (CSE:GEN; OTCBB:GMXAY) said GSK submitted an sBLA to FDA seeking to expand the label for Arzerra ofatumumab to include...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >